Hematoma Postoperative
9
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
67%
6 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery
Application of the "Haemoblock" in Pacemaker Patients
The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery
Use of Tranexamic Acid in Reduction Mammoplasty
Tranexamic Acid for Alloplastic Breast Reconstruction
Topical Tranexamic Acid for Bilateral Breast Reduction Surgery
Study to Evaluate the Performance of a Sustained Vacuum System
SEroma Reduction pOst MAstectomy "SEROMA Study"
Prevention of Pocket Hematoma After Implantation Cardiovascular Implanted Electronic Devices